Clinical Trial

A Study on the Effectiveness of a Dietary Supplement FitoAvia for Jet Lag

Completed
View on ClinicalTrials.gov →
Summary
Purpose of the study: Evaluation of the effects of dietary supplement Fitoavia in people with dyssynchrony Objectives of the study: 1. Assessment of the condition of patients with jet lag of 4 hours or more 2. Determination of the day of normalization of the circadian rhythm in each group 3. Assessing the quality of life of patients. 4. Assessment of the economic effectiveness of the therapy performed 5. Evaluation of the results of daily software testing for "staff" of at least 12 people from each group Randomization Block randomization with stratification. Randomization sheets will be provided prior to the start of the study. Sample size Total number of patients included in the study: up to 120. Study groups Group 2 - at least 60 patients in each group (Fitoavia/Placebo) with stratification within each group: Group 1, patients receiving: Fitoavia. Group 2 patients who received: Placebo. Stratification implies uniform inclusion of patients according to the amount of jet lag.
Trial Details
NCT Number NCT07695870
Lead Sponsor MiraxBioPharma
Conditions Jet Lag Disorder, Jet Lag, Jet Lag Type Insomnia, Cognition Improvement
Enrollment 120 participants
Start Date 2025-10-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-10